cell-mediated immunity

(redirected from cell-mediated)
Also found in: Medical, Encyclopedia.

cell-mediated immunity

n.
Immunity involving cells, such as T cells and phagocytes, in contrast with humoral immunity, which involves soluble proteins (antibodies). Also called cellular immunity.

cell′-me`diated immu′nity


n.
immunity conferred to an individual through the activity of T cells, involving the direct destruction of viruses, foreign particles, etc. Compare antibody-mediated immunity.
[1970–75]
References in periodicals archive ?
M2 EQUITYBITES-October 18, 2016-Accurexa partners with StemImmune to develop stem cell-mediated immunotherapy for cancer patients
M2 PHARMA-October 18, 2016-Accurexa partners with StemImmune to develop stem cell-mediated immunotherapy for cancer patients
The indication of these findings, the authors conclude, is that cell-mediated immunity is affected by ZV and enhanced by a stronger, or more recent, dose.
The Type 1 reaction (T1R) is a delayed hypersensitivity reaction associated with sudden alteration of cell-mediated immunity associated with a shift in the patient's position in the leprosy spectrum.
Objective: Multiple sclerosis (MS) is a prototypic CD4+ T cell-mediated autoimmune disease that damages the central nervous system.
The groups were acute T cell-mediated rejection group (group A, 27 cases), chronic active antibody-mediated rejection group (group B, 9 cases), chronic active T cells mediated rejection group (group C, 5 cases), borderline lesions group (group D, 13 cases), normal group without obvious acute rejection or injury of immunosuppressant toxicity (group E, 11 cases), and recurrence of allograft nephropathy group (group F, 4 cases).
The deal includes the acquisition of Cylex's core product, ImmuKnow, a noninvasive biomarker ofimmune function that assesses cellular immune status by detecting cell-mediated immunity (CMI) in populations undergoing immunosuppressive therapy for an organ transplant.
Oral tolerization to autoantigens suppresses animal models of T cell-mediated autoimmune disease, including two models of rheumatoid arthritis.
The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
They assessed both cell-mediated and humoral immunity conferred by the pertussis booster and found that both types of immunity persisted for 5 years or more in subjects who had received the booster at ages 11-13 years.
In what they described as the first long-term study that assessed both cell-mediated and humoral immunity conferred by the pertussis booster, the researchers found that both types of immunity persisted for 5 years or more in subjects who had received the booster at ages 11-13 years.
We conducted a prospective study of 60 patients in a tertiary care referral center to ascertain the status of cell-mediated immunity as determined by delayed hypersensitivity reactions in patients with nasopharyngeal carcinoma (NPC) or allergic rhinitis.